Pathology and genetics of tumours of endocrine organs

By R. DeLellis. 2004

1,859 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/c028f6874de6b4425fa7a2c0c1ec6ff695b5eaa1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Y. Nikiforov
2. E. Brambilla
3. W. Travis
4. G. Rindi
5. G. Francis
6. W. Young
7. A. G. Robertson
8. Graeme Eisenhofer

Citations in the corpus

• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer (2009, unknown): “This tumor is currently designated by the World Health Organization as a histopathologic variant of follicular carcinoma (441).”
• Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. (2014, background): “Paragangliomas also arise from parasympathetic ganglia located along the glossopharyngeal and vagal nerves in the neck and at the base of the skull (3); these do not produce catecholamines.”
• Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association (2009, unknown): “Familial CCH is a preneoplastic lesion as opposed to secondary CCH, which is associated with much less, if any, malignant potential (21).”
• Pathology and genetics of tumours of the lung , pleura, thymus and heart (2004, background): “The initial karyotype showed two abnormal clones: 48, XY; +8; +8; del(9)(q22; q32) [19] and 46, XY, t(1;16)(q25;p12) [7].”
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer (2015, methodology): “Subtypes of PTC in pediatrics include the following histologic variants: classic, solid, follicular, and diffuse sclerosing (25,29).”
• Long‐term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation (2007, unknown): “Patient demographics (N 5 2587) Sex Women 2268 (88) Men 319 (12) Age, y Mean, y 50 Range, y 18–96 18–30 258 (10) 31–40 470 (18) 41–50 684 (26) 51–60 590 (23) 61–70 362 (14) [70 223 (9) No.”
• TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system (2007, background): “G3 indicates a poorly differentiated neuroendocrine carcinoma with high mitotic counts/Ki-67 index, fields of necrosis, significantly reduced chromogranin A expression and intense staining for synaptophysin, meeting the current WHO histological criteria [5, 8, 34].”
• Molecular genetics and diagnosis of thyroid cancer (2011, background): “Adapted from Expert Reviews of Molecular Diagnostics 8 (1), 83–89 (2008)”
• Epigenetics: The Science of Change (2006, methodology): “The size limits indicated for T1 are those defined by the WHO for tumors with “benign behavior” according to site-specific clinicopathological correlations [5, 7, 31].”
• Comprehensive molecular characterization of pheochromocytoma and paraganglioma (2017, background): “Metastatic events were defined as the occurrence of distant metastases in anatomical locations where chromaffin tissue is not normally present, as per WHO definition (DeLellis et al., 2004).”